Dyne Therapeutics, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2021 | $-119.6M | $-123.2M | $3.6M | $17.5M |
| FY2022 | $-153.6M | $-156.7M | $3.1M | $15.2M |
| FY2023 | $-188.2M | $-188.9M | $729.0K | $20.0M |
| FY2024 | $-292.4M | $-294.7M | $2.4M | $45.9M |
| FY2025 | $-403.2M | $-405.1M | $1.9M | $45.9M |